Society of Gynaecological Oncology Congress 2026: Panos Konstantinopoulos, MD, PhD | Dana-Farber
Panos Konstantinopoulos, MD, PhD, of Dana-Farber Cancer Institute discusses clinical activity of ACR-368 in patients with endometrial carcinoma prospectively selected by oncosignature. Data on the phase 2 study was presented at the European Society of Gynaecological Oncology Congress 2026. Video published April 20, 2026
🎬 More from Dana-Farber Cancer Institute
Understanding Chemo Neuropathy: A Webinar by the Older Adults with GI Cancer Program | Dana-Farber
19 views
Learning About Chronic Lymphocytic Leukemia | Lymph Notes: A Lymphoma Learning Series
112 views
ASCO26: David Reardon, MD Glioblastoma Vaccine | Dana-Farber Cancer Institute
106 views
Society of Gynaecological Oncology Congress 2026: Tara Berman, MD | Dana-Farber Cancer Institute
30 views
ASCO26: Julia Rotow, MD Silevertinib in Lung Cancer | Dana-Farber Cancer Institute
55 views
ASCO26: Atish Choudhury, MD, PhD A-DREAM/Alliance A032101 | Dana-Farber Cancer Institute
38 views